The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Apel Daniel Joseph since 2026.
This trader's CIK number is 2081169.
At the time of last reporting, Apel Daniel Joseph was the Chief Financial Officer of Arrowhead Pharmaceuticals, Inc.. (stock ticker symbol ARWR).
Also see all insider trading activities at Arrowhead Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ARWR | 0 | $0 | 13,095 | $927,479 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-22 | ARWR | Sale | 13,095 | 70.83 | 927,479 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Apel Daniel Joseph (Chief Financial Officer of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.